Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

170 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT).
Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J. Poynard T, et al. Among authors: ideo g. Lancet. 1998 Oct 31;352(9138):1426-32. doi: 10.1016/s0140-6736(98)07124-4. Lancet. 1998. PMID: 9807989 Clinical Trial.
Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study.
Idéo G, Bellobuono A, Tempini S, Mondazzi L, Airoldi A, Benetti G, Bissoli F, Cestari C, Colombo E, Del Poggio P, Fracassetti O, Lazzaroni S, Marelli A, Paris B, Prada A, Rainer E, Roffi L. Idéo G, et al. Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1203-7. doi: 10.1097/00042737-199911000-00003. Eur J Gastroenterol Hepatol. 1999. PMID: 10563527 Clinical Trial.
Interferon-ribavirin combination therapy for chronic hepatitis C.
Schalm SW, Brouwer JT, Chemello L, Alberti A, Bellobuono A, Ideo G, Schwartz R, Weiland O. Schalm SW, et al. Among authors: ideo g. Dig Dis Sci. 1996 Dec;41(12 Suppl):131S-134S. doi: 10.1007/BF02087889. Dig Dis Sci. 1996. PMID: 9011471
170 results